November 14th 2024
The findings of the study suggest HS is associated with pregnancy complications and adverse outcomes for both mothers and offspring.
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
The Ultrasound Detection of Chromosomal Anomalies
Adapted from "The Ultrasound Detection of Chromosomal Anomalies
Read More
A Discussion of Natural Hormones
July 26th 2011The request for "natural hormones" is nearly universal. But there is a lot of misunderstanding regarding this idea. What is natural? Compounds derived from nature? Or compounds from pharmaceutical companies that are structurally similar to hormones produced by the ovaries?
Read More
Provider Training Shapes Attitudes, Treatment Choices for Early Pregnancy Failure
July 26th 2011Currently in the United States, early pregnancy failure (EPF) appears to be predominantly treated by expectant management and operating room–based uterine evacuation, even though research data have demonstrated that misoprostol and office uterine evacuation can safely evacuate a uterus in the context of induced abortion. In addition, research data indicate that women accept and actually prefer treatment with office uterine evacuation or misoprostol after EPF. So why aren’t these procedures being performed more regularly?
Read More
ACOG Committee Opinion: Screening for Vitamin D Not Recommended
July 24th 2011Routine screening of pregnant women for vitamin D deficiency is not recommended, according to a new Committee Opinion of The American College of Obstetricians and Gynecologists. Although severe vitamin D deficiency during pregnancy has been linked with abnormal skeletal development, congenital rickets, and bone fractures in newborns, most pregnant women obtain enough vitamin D through prenatal vitamins, fortified milk and juice, fish oils, and sunlight exposure.
Read More
Implantable Devices Should Be Offered as First-Line Contraception
July 24th 2011The most effective forms of reversible contraception available to date are long-acting reversible contraceptives (LARCs), which include intrauterine devices (IUDs) and implants.1 According to The American College of Obstetricians and Gynecologists (The College), LARCs are safe for almost all women of reproductive age, including nursing mothers, adolescents, and women who have not yet had a child, and The College recommends them as first-line contraceptive methods.
Read More
Placental Localization by Transperineal Sonography in Antepartum Hemorrhage
July 22nd 2011Transperineal and transabdominal sonography were done for 180 patients attending Benha University Hospitals at 28-40 weeks gestational age with an antepartum hemorrhage in the period between July, 1995 and October, 1996.
Read More
Maternal Serum Marker Screening for Down Syndrome
July 22nd 2011Prenatal screening for Down syndrome is continuously being refined. Initially, the screen was limited to the health care provider's consideration of the mother's age at delivery, once the association between advanced maternal age (i.e. maternal age 35 or older at delivery) and increased risk for Down syndrome was recognized.
Read More
First-Trimester Aneuploidy Screening A Combined Approach
July 22nd 2011Prenatal testing for Down syndrome has gained importance--and urgency--as more women delay pregnancy into their later reproductive years. A first-trimester screening technique that combines use of maternal serum markers with ultrasonographic assessment may offer reliable answers sooner than do other available tests.
Read More
Maternal Position During the First Stage of Labor: A Systematic Review
July 21st 2011Policy makers and health professionals are progressively using evidence-based rationale to guide their decisions. There has long been controversy regarding which maternal position is more appropriate during the first stage of labor.
Read More
Archive of Articles by David Hutchon, BSc, MB, ChB, FRCOG, UK OBGYN.net Editorial Advisor
July 21st 2011"Back to the Future" for Hermaani Boerhaave, or, "A rational way to generate ultrasound scan charts for estimating the date of delivery", by David Hutchon, BSc, MB, ChB, FRCOG How to use Bayes theorem to estimate sequential conditional risks. Odds ratio or Risk: that is the question! by David Hutchon, BSc, MB, ChB, FRCOG and A. Khattab, MD , Dept of Obstetrics and Gynaecology, Memorial Hospital, Darlington, UKOnline Calculators by Dr. Hutchon Down Syndrome risk calculator with growth calculator UK dates i.e. D/M/Y versionDown Syndrome risk calculator (using Hecht and Hook formula) with growth calculator UK dates i.e. D/M/Y versionDown Syndrome risk calculator with growth calculator US dates i.e. M/D/Y versionDown Syndrome risk calculator using gestation specific likelihood ratios for both CRL and BPD measurements. UK dates i.e. D/M/Y versionDown Syndrome risk calculator using gestation specific likelihood ratios for both CRL and BPD measurements. US dates i.e. M/D/Y versionDown Syndrome risk calculator with growth calculator FRENCH version translation by Docteur Eric Launay, Paris. Down Syndrome risk calculator with growth calculator SLOVENIA version translation by Mag. Stanko Pu?enjak, dr. med.Down Syndrome risk calculator with growth calculator ITALIAN version translation by D Spagnolo-HSRaffaele Milano.Software to generate your own customised EDD calculator (UK date style entry)Software to generate your own customised EDD calculator (US date style entry)Simple fetal weight calculatorChicken pox in pregnancy: - decision assistanceA customised (for fetal sex, parity, maternal age) EDD calculator for the Darlington population - (see how to make your own)Risk of malignancy index calculator for ovarian tumoursCritical Appraisal Page (with off-line calculator package) for single treatment trialCritical Appraisal Page (with off-line calculator package) for Diagnostic testCalculator for confidence intervals of relative risk.Calculator for confidence intervals of odds ratioA whole range of statistical calculatorsGenerates a table for any ultrasound parameter measurement converted to gestation using any polynomial equationGenerates a table for gestation to any ultrasound parameter measurement using any polynomial equationCalculator for risk of Down syndrome using second trimester US markers using work published by Greggory De VoreRisk of Abruptio Placentae as published by Baumann P et al Mathematic modeling to predict abruptio placentae. Am J Obstet Gynecol 2000;183:815-22
Read More
First Trimester Nuchal Translucency Screening: Should It Be Standard of Care?
July 21st 2011Screening for Down syndrome has evolved significantly over the last number of years. Much research has been presented describing sonographic features that may be useful for the prenatal detection of Down syndrome, ranging from second trimester “soft markers” such as short femur, nuchal fold enlargement, or echogenic intracardiac foci, to first trimester features such as increased nuchal translucency or absent fetal nose bone.
Read More
Ethical Issues in First-Trimester Screening
July 21st 2011It has previously been argued that “prenatal informed consent for sonogram be accepted as an indication for the prudent use of obstetric ultrasonography performed by qualified personnel.” We extend this argument to the use of ultrasound screening for aneuploidy in the first trimester.
Read More
Ultrasound Is the Only Monitoring Modality Necessary For Ovulation Induction
July 21st 2011Ovulation induction is based on the administration of gonadotropins in order to enhance fertility. Daily administration of the drug causes a supra-physiological increase in serum FSH leading to the recruitment of a larger cohort of follicles, further causes their growth and development, and finally, triggering ovulation of usually more than one follicle.
Read More
Benefits and Challenges of Transitioning Preterm Infants to At-Breast Feedings
July 21st 2011Upon hospital discharge it is not unusual for mothers of preterm infants to continue to meet all or most of their infants' nutritional needs through bottle feedings of expressed breast milk (EBM) because of infants' physiological immaturity and maternal concerns with an inadequacy of milk supply.
Read More
Measuring Perinatal Complications: Methodologic Issues Related to Gestational Age
July 20th 2011Perinatal outcomes differ by week of gestational age. However, it appears that how measures to examine these outcomes vary among various studies. The current paper explores how perinatal complications are reported and how they might differ when different denominators, numerators, and comparison groups are utilized.
Read More